Infectious Disease
A shot in the spring – How NACI and CIQ recommends you protect your patients at risk of severe COVID-19
DURATION
1 hr
PROFESSION
Physician
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2024-03-27
The National Advisory Committee on Immunization (NACI) and the Comité sur l’immunisation du Québec (CIQ) has updated their COVID–19 booster recommendations for patients at high–risk of COVID–19. Although many patients feel that their risk of severe COVID–19 is minimal, there are a large portion of
Canadians who are at significantly elevated risk. This webinar will address the key issues that you will need to know to mitigate severe COVID–19 risk in these vulnerable populations.
This webinar has received funding from Moderna Biopharm Canada Inc
Faculty
Moderator - Christine Palmay, MD, CFPC
Vivien Brown, MDCM, CCFP, FCFP, NCMP
Marla Shapiro, C.M, MDCM, CCFP, MHSc, FRCPC, FCFP, NCMP
Alex Carignan, MD, FRCPC
Learning objectives
- Discuss the current COVID-19 bivalent booster recommendations for Canadians
- Determine which patients should receive a bivalent booster in Spring 2023
- Explain the rationale for the current COVID-19 booster recommendations
- Approach and recommend COVID-19 bivalent boosters for specific patients in practice